Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit! If you are interested in the 2026 event, please get in touch at info@hansonwade.com
Continue the conversation at the next event in series!
January 27-29, 2026
Boston, MA
Download Your Complimentary Copy of the Agenda
Top Reasons to Download:
- 25+ Expert Speakers
- 3 Days of RNA-Targeted Content
- 2 Interactive Workshops on Functional Binder Discovery
- Investments & Deals Panel
*Having trouble downloading the brochure?
Let us know and we'll email a copy straight to your inbox.
Go Beyond Splice Modulators with the Next-Generation of RNA-Targeted Drugs
Harnessing Covalent & Proximity Inducing Molecules Against RNA
Jennifer Petter
Chief Scientific Officer
Arrakis Therapeutics Inc.
Nikolai Naryshkin
Chief Scientific Officer
Ribonaut Therapeutics
Structure & AI-Based Drug Design to Discover Functional RNA Binders
Ella Czarina Morishita
Chief Scientific Officer
Veritas In Silico Inc.
Ramya Rangan
Senior Scientist, ML/Bio
Atomic AI
Targeting RNA-RBP & Peptide-Ribosome Complexes
Jerry McMahon
President & Chief
Executive Officer
STORM Therapeutics Ltd.
Paige Diamond
Senior Investigator
Interdict Bio
Directly Binding RNA Targets for Translation Inhibition
David Sparkman-Yager
Chief Technology Officer
Wayfinder Biosciences
Shunichi Kashida
Representative Director, President & CEO
xFOREST Therapeutics